KRX Aesthetics PD-13 Therapy
NDC 84755-0010, KRX Aesthetics PD-13 Therapy, spray, from KRX RESOURCES SDN. BHD..
- Product NDC
- 84755-0010
- Status
- Listed
- Labeler
- KRX RESOURCES SDN. BHD.
- Dosage form
- SPRAY
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/84755-0010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHYL AMINOLEVULINATE HYDROCHLORIDE1.95 mg/15mL
Pharmacologic classes
Porphyrin Precursor [EPC]; Porphyrinogens [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 84755-0010-1 | 84755001001 | 15 mL in 1 PACKAGE (84755-0010-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 84755-0010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/84755-0010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 84755-0010. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.